Suzano (SUZB3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Apr, 2026Executive summary
Achieved record sales and shipment volumes in pulp (12.5 million tons) and paper/packaging (1.5 million tons) for 2025, with strong year-over-year growth and operational excellence across key regions.
Strategic initiatives included the acquisition of a 51% stake in a global joint venture with Kimberly-Clark and successful integration of US paperboard assets, supporting business growth and international expansion.
Operational improvements and the Ribas do Rio Pardo operation contributed to the lowest cash production cost since 2021, enhancing structural competitiveness.
Demonstrated resilience and competitiveness with strong operational and free cash flow despite a low price cycle and challenging market conditions.
Financial highlights
Generated $400 million in free cash flow in Q4 2025, reducing net debt to $12.6 billion and leverage to 3.2x; liquidity increased to US$6.6 billion.
Adjusted EBITDA for 2025 was R$21.7 billion, with Q4 2025 EBITDA at $4.8 billion (up 8% QoQ) and R$5.6 billion (up 7% QoQ), supported by higher volumes and better prices.
Net income was R$116 million in Q4 2025, a recovery from a R$6.7 billion loss in Q4 2024.
Free cash flow yield (LTM) was 16.7%, and ROIC (LTM) was 11.5%.
Achieved lowest cash cost since Q4 2021 at BRL 778/ton, a 3% reduction from Q3 2025.
Outlook and guidance
Expect lower sales volumes in Q1 2026 due to seasonality, but anticipate price improvements from announced increases and favorable pulp market dynamics.
2026 cash production cost of pulp projected to remain broadly in line with Q4 2025 levels; continued focus on reducing operational disbursement and net debt.
Maintenance downtimes in Q1 and Q2 2026 will constrain pulp availability and require inventory buildup.
CAPEX guidance for 2026 reduced by nearly 20% year-on-year, with a capital budget of R$10.9 billion.
Joint venture with Kimberly-Clark on track for mid-2026 closing, expected to enhance competitiveness.
Latest events from Suzano
- Disciplined growth, global expansion, and sustainability drive robust financial and operational results.SUZB3
Investor presentation1 Apr 2026 - EBITDA up 60% year-over-year, but net loss of R$3.77B on FX and derivative impacts.SUZB3
Q2 20241 Feb 2026 - EBITDA and sales volumes surged, with Ribas ramp-up and acquisitions boosting performance.SUZB3
Q3 202418 Jan 2026 - Cost leadership, operational excellence, and disciplined capital allocation drive growth.SUZB3
Investor Day 202411 Jan 2026 - Record sales and EBITDA driven by Ribas ramp-up, but FX losses led to a net loss.SUZB3
Q4 20248 Jan 2026 - Focus is on competitiveness, cost reduction, and disciplined growth amid market shifts.SUZB3
Investor Day 202512 Dec 2025 - Strong sales growth, robust cash flow, and major strategic moves marked the quarter.SUZB3
Q2 202523 Nov 2025 - Net income rose to R$6.3B in 1Q25, with stable leverage and strong free cash flow.SUZB3
Q1 202518 Nov 2025 - JV creates a global tissue leader with $3.3bn revenue, $175M synergies, and strong diversification.SUZB3
Investor Update12 Nov 2025